Physiological roles of angiotensin-converting enzyme 2

被引:28
作者
Danilczyk, U
Eriksson, U
Oudit, GY
Penninger, JM
机构
[1] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada
[3] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria
[4] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland
[5] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland
[6] Univ Toronto, Fac Med, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5S 2E3, Canada
关键词
angiotensin-converting enzyme 2; knockout mice; renin-angiotensin system;
D O I
10.1007/s00018-004-4241-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin-converting enzyme 2 (ACE2) is a recently discovered homologue of the key enzyme of the renin-angiotensin system, the angiotensin-converting enzyme. The ACE2 enzyme is mainly expressed in cardiac blood vessels and tubular epithelia of the kidneys. Together with ACE2's unique metallocarboxypeptidase activity, the restricted tissue distribution suggests a distinctive physiological function in blood pressure, blood flow and fluid regulation. The ace2 gene was mapped to quantitative trait loci affecting susceptibility to hypertension in rats. Furthermore, ACE2 appears to be a negative regulator of ACE in the heart. ACE2 messenger RNA and protein levels are substantially regulated in the kidney of diabetic and pregnant rats. The mechanism of ACE2 function and its physiologic significance are not yet fully understood; however, as ACE2 differs in its specificity and physiological role from ACE, this opens a new potential venue for drug discovery aimed at cardiovascular disease, hypertension and diabetic complications.
引用
收藏
页码:2714 / 2719
页数:6
相关论文
共 40 条
  • [1] Allred A. J., 2002, 35 ANN M AM SOC NEPH
  • [2] BROSNIHAN KB, 2003, HYPERTENSION
  • [3] Angiotensin-converting enzyme 2 is an essential regulator of heart function
    Crackower, MA
    Sarao, R
    Oudit, GY
    Yagil, C
    Kozieradzki, I
    Scanga, SE
    Oliveira-dos-Santos, AJ
    da Costa, J
    Zhang, LY
    Pei, Y
    Scholey, J
    Ferrario, CM
    Manoukian, AS
    Chappell, MC
    Backx, PH
    Yagil, Y
    Penninger, JM
    [J]. NATURE, 2002, 417 (6891) : 822 - 828
  • [4] INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME FOR TREATMENT OF HYPERTENSION
    CUSHMAN, DW
    ONDETTI, MA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (13) : 1871 - 1877
  • [5] A story of two ACEs
    Danilczyk, U
    Eriksson, U
    Crackower, MA
    Penninger, JM
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (04): : 227 - 234
  • [6] A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
    Donoghue, M
    Hsieh, F
    Baronas, E
    Godbout, K
    Gosselin, M
    Stagliano, N
    Donovan, M
    Woolf, B
    Robison, K
    Jeyaseelan, R
    Breitbart, RE
    Acton, S
    [J]. CIRCULATION RESEARCH, 2000, 87 (05) : E1 - E9
  • [7] EFFECT OF CHRONIC ENALAPRIL TREATMENT ON ENZYMES RESPONSIBLE FOR THE CATABOLISM OF ANGIOTENSIN-I AND FORMATION OF ANGIOTENSIN-II
    DRUMMER, OH
    KOURTIS, S
    JOHNSON, H
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 39 (03) : 513 - 518
  • [8] Vasoactive potential of the B1 bradykinin receptor in normotension and hypertension
    Duka, I
    Kintsurashvili, E
    Gavras, I
    Johns, C
    Bresnahan, M
    Gavras, H
    [J]. CIRCULATION RESEARCH, 2001, 88 (03) : 275 - 281
  • [9] Just the beginning: Novel functions for angiotensin-converting enzymes
    Eriksson, U
    Danilczyk, U
    Penninger, JM
    [J]. CURRENT BIOLOGY, 2002, 12 (21) : R745 - R752
  • [10] Esther CR, 1996, LAB INVEST, V74, P953